2′-substituted-N6-substituted purine nucleotides for RNA virus treatment
US11975016B2 · kind B2 · utility
0Cited by
175References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 22, 2021 |
| Grant date | May 7, 2024 |
| Priority date | — |
| Expiry date | Sep 22, 2041 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The use of described compounds or pharmaceutically acceptable salts or compositions thereof for the treatment of a host infected with an RNA virus other than HCV, or other disorder more fully described herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.